Biocon shares near 52-week high; Malaysian arm gets approval from European Medicines Agency for new product

Biocon shares trade near a 52-week high.

Biocon's Malaysian arm received approval from the European Medicines Agency for Semglee production.

The approval allows Semglee to be manufactured at the Malaysian facility.